UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...
AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
U.S, January 13, 2020 (GREENENTREPRENEUR) It really depends on your tolerance and what conditions you are treating, but here we remove some of the dosing mystery.
The brave new world of cannabidiol or CBD-infused products is growing. That means more product choices and...
U.S, July 12, 2021 (ANALYTICALCANNABIS) With cannabis cultivation operating underground throughout much of the 20th century, the species lost a significant amount of genetic diversity. Just like with alcohol prohibition during the 1920s, cannabis prohibition served to push THC levels upward to the exclusion of other traits.
UNITED STATES, June 24, 2019 (Web MD)- Cannabidiol, or CBD, already being researched and used for anxiety, insomnia, epilepsy and pain, may be the next superbug fighter for resistant infections, a new study suggests.The researchers tested CBD against a wide variety of bacteria, ''including bacteria that have become resistant to the most commonly...